Scientist to Senior Scientist
Angitia
Scientist to Senior Scientist
Angitia
Clinical-stage biotech developing bone therapeutics
工作地点 | Location :
广州 Guangzhou
岗位职责 | Position responsibilities and duties:
任职资格/Qualifications:
教育背景 | Education
工作经验 | Experience
专业技能 | Technical Skills
必须具备 | Required
加分项 | Preferred
核心能力 | Core Competencies
注:最终岗位将根据候选人的工作年限、技能和经验水平综合确定。Note: the final job title will be commensurate with the candidate’s seniority, skills and level of experience.
About Angitia
Established in June 2018, Angitia Biopharmaceuticals is a multinational research and development enterprise focusing on discovery and development of new drugs for grievous bone, muscle, and joint diseases. Our mission is to discover, develop and commercialize breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built an organization distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talent who are innovative, ambitious, and great team players to join our vibrant group.
Angitia Biopharmaceuticals develops biologic therapies for serious musculoskeletal diseases, with multiple candidates in Phase 2 and Phase 3. Its bispecific antibodies and other biologics aim to both stimulate bone formation and inhibit bone degradation to improve skeletal health. The company differentiates itself through deep bone biology expertise, translational medicine experience, and global research collaborations that support clinical progress. The aim is to deliver new treatments that improve structural outcomes and quality of life while advancing toward regulatory milestones.
Explore more opportunities at Angitia